Yahoo Finance

Medtronic InterStim System Shows Five-Year Positive Results

One of the world’s largest medical technology, services and solutions companies, Medtronic plc MDT is making efforts to expand its Pelvic Health & Gastric Therapies business, part of the company's ...
Nasdaq

Medtronic Receives FDA Approval for Expanded MRI Labeling of InterStim™ SureScan™ MRI Leads

DUBLIN, Feb. 18, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received approval from the United States Food and Drug Administration ...
Yahoo Finance

Medtronic Begins Post-Market, Real-World Study of the InterStim™ Micro System

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Nasdaq

Medtronic Announces FDA Submission for InterStim™ Micro Neurostimulator and SureScan™ MRI Leads

Smaller, Rechargeable Device Will Provide More Choices for Patients Suffering with Bladder and Bowel Control Issues SureScan™ MRI Leads Will Provide Full-Body MRI Conditional Labeling The rechargeable ...
FierceHealthcare

Study Shows Medtronic InterStim® Therapy Improves Bowel Control and Related Quality of Life Issues at Three Years

InterStim Therapy for Bowel Control Recently Approved by the U.S. FDA MINNEAPOLIS--(BUSINESS WIRE)-- Medtronic, Inc. (NYSE: MDT) announced today that newly published data from a multicenter, ...
MD&M East

Medtronic Ups Its Game in Sacral Neuromodulation for Bowel and Bladder Control

Medtronic and Axonics have been going toe-to-toe in sacral neuromodulation — a fast-growing market that was monopolized by Medtronic until September 2019 — and the incumbent may have just gained the ...
FierceBiotech

Medtronic Submitted Pre-Market Approval Application For FDA Approval of InterStim Therapy for Fecal Incontinence

October 22, 2008--MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT), today announced that it has submitted its Pre-Market Approval (PMA) application with the U.S. Food and Drug Administration ...
StarTribune

Medtronic ratchets up patent spat for device that aids in bladder, bowel control

Medtronic is upping the ante in a patent dispute with competitor Axonics Inc. that has already lasted more than four years. The dispute centers on Medtronic’s InterStim device, an implanted ...
MD&M East

Medtronic Scores FDA Nod for Next-Gen InterStim

Medtronic continues to up its game in sacral neuromodulation. FDA approved InterStim X, the next generation of the company's InterStim portfolio's recharge-free device. Medtronic said implants have ...
Stockhouse

Medtronic Receives FDA Approval for Expanded MRI Labeling of InterStim(TM) SureScan(TM) MRI Leads

DUBLIN , Feb. 18, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received approval from the United States Food and Drug Administration ...
Benzinga.com

Study Shows Medtronic InterStim® Therapy Improves Bowel Control and Related Quality of Life Issues at Three Years

announced today that newly published data from a multicenter, prospective trial show that sacral nerve stimulation using Medtronic InterStim® Therapy reduced incontinent episodes and increased quality ...